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Consumption of foods high in saturated fatty acids
(FAs) as well as elevated levels of circulating free
FAs are known to be associated with T2D. Though
previous studies showed inflammation is crucially
involved in the development of insulin resistance,
how inflammation contributes to b cell dysfunction
has remained unclear. We report here the saturated
FA palmitate induces b cell dysfunction in vivo by
activating inflammatory processes within islets.
Through a combination of in vivo and in vitro studies,
we show b cells respond to palmitate via the TLR4/
MyD88 pathway and produce chemokines that
recruit CD11b+Ly-6C+ M1-type proinflammatory
monocytes/macrophages to the islets. Depletion of
M1-type cells protected mice from palmitate-
induced b cell dysfunction. Islet inflammation also
plays an essential role in b cell dysfunction in T2D
mouse models. Collectively, these results demon-
strate a clear mechanistic link between b cell
dysfunction and inflammation mediated at least in
part via the FFA-TLR4/MyD88 pathway.
INTRODUCTION
Obesity has reached epidemic proportions around the world due
to a modern lifestyle characterized by increased consumption of
foods rich in energy and saturated fat, combined with reduced
physical activity (Hill, 2006). This obesity epidemic has resulted
in dramatic increases in the incidences of obesity-associated
diseases, including type 2 diabetes (T2D), and represents518 Cell Metabolism 15, 518–533, April 4, 2012 ª2012 Elsevier Inc.a worldwide health crisis. Numerous studies have shown that
insulin resistance precedes the development of hyperglycemia
in subjects that eventually develop T2D (Prentki and Nolan,
2006). However, T2D only develops in insulin-resistant subjects
after the onset of pancreatic b cell dysfunction (Leahy, 2005).
Inflammation is increasingly known to play a key role in the
initiation and development of obesity-associated diseases. For
instance, elevated levels of circulating proinflammatory cyto-
kines are observed in obese subjects and those with T2D
(Schenk et al., 2008). Mechanistically, proinflammatory signaling
pathways can inhibit insulin signaling, providing a link between
inflammation and insulin resistance. By contrast, the involve-
ment of inflammation in b cell failure in T2D is poorly understood,
although a T cell-mediated autoimmune response against b cells
appears to be a primary pathogenic mechanism in type 1 dia-
betes (T1D) (Mallone and van Endert, 2008). Recent reports
suggest similar inflammatory processes are also activated within
T2D islets. For instance, expression of interleukin (IL)-1b, which
is involved in the autoimmune processes leading to T1D, is upre-
gulated in the islets of patients and animal models with T2D, and
an IL-1 receptor antagonist reportedly improves blood glucose
levels and b cell function in T2D patients (Donath and Shoelson,
2011; Larsen et al., 2007). Accumulation of macrophages within
islets has also been observed in T2D subjects (Richardson et al.,
2009), further suggesting activation of inflammation. However,
the mechanism by which the accumulation of macrophages
within islets is initiated and the extent to which the accumulated
macrophages contribute to b cell dysfunction is not yet clear.
Free fatty acid (FFA) levels are elevated in obese subjects
(Boden, 2008) and are an independent predictor of future T2D
(Charles et al., 1997). High intake of saturated fatty acids (FAs)
has also been linked to higher risks of T2D (Rise´rus et al.,
2009) and coronary artery disease. Previous studies have shown
that palmitate, the most abundant saturated FFA in blood,
inhibits insulin signaling in liver, muscle, and fat cells in vitro
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2009). These studies have also shown the deleterious effects
of FFAs, collectively termed ‘‘lipotoxicity,’’ on b cells in vitro
(Weinberg, 2006). Based mainly on the findings of in vitro
studies, it was proposed that b cell lipotoxicity is directly induced
by palmitate at least in part via pathways involving endoplasmic
reticulum (ER) stress and reactive oxygen species (ROS) (Cnop,
2008; Fonseca et al., 2011). Similarly, in vivo infusion of emulsi-
fied soybean triglyceride impairs b cell function in rats and
humans (van Raalte et al., 2010). However, the molecular mech-
anisms by which FFAs induce b cell dysfunction in vivo remain
poorly understood.
Potential molecular links between FFAs andmetabolic disease
are the toll-like receptors (TLRs). TLRs are pattern recognition
receptors that initiate innate immune responses upon recogni-
tion of a wide range of pathogen-associated molecular patterns,
including lipids, lipoproteins, and proteins (Kawai and Akira,
2009). A growing body of evidence suggests they are also
capable of responding to endogenous ligands, including lipids
(Fessler et al., 2009). For instance, saturated FAs activate the
inflammatory program via TLR4 in macrophages (Lee et al.,
2001; Suganami and Ogawa, 2010). Moreover, recent studies
showed that TLR4 signaling is important for high fat diet-induced
insulin resistance, presumably by mediating inflammatory
responses within adipose tissue and skeletal muscle (Shi et al.,
2006; Suganami and Ogawa, 2010). Within islets, TLR4 is ex-
pressed in b cells (Goldberg et al., 2007), and the chemokine
CXCL10 was recently reported to bind to TLR4 and induce
b cell apoptosis (Schulthess et al., 2009). Collectively, these
studies suggest that the TLR4 pathway may play a key role in
b cell dysfunction in T2D.
In the present study, we established a method to selectively
increase the circulating free palmitate level in mice and analyzed
its effects on b cell function. We found that palmitate induces
b cell dysfunction in vivo by activating inflammatory processes
within islets. We also show that b cells sense palmitate via the
TLR4/MyD88 pathway and produce chemokines, which in turn
recruit M1-type proinflammatory monocytes/macrophages to
the islets. Depletion of M1-type cells ameliorated the b cell
dysfunction induced by palmitate, confirming the causative
involvement of M1-type cells. M1 macrophage accumulation
was also important for b cell dysfunction in T2D models db/db
and KKAy mice. Taken together, the results of the present study
establish a molecular link between islet inflammation and b cell
dysfunction in T2D.
RESULTS
Palmitate Induces b Cell Dysfunction In Vivo
Saturated FAs such as palmitate reportedly exert adverse effects
on a variety of cultured cells in vitro, including b cells (Cnop,
2008; Prentki and Nolan, 2006). To the best of our knowledge,
however, the effects of palmitate on b cells have never been
directly tested in vivo by selectively increasing circulating palmi-
tate levels. Instead, infusion of lipids was previously accom-
plished using emulsified triglycerides derived from soybean or
lard oil, which contain a variety of FA residues, often together
with heparin, which activate lipoprotein lipase and promote
FFA release from the infused triglycerides and from lipoproteinsCin the circulation (Teusink et al., 2003). Most likely, however,
each FA species will affect cellular function differently. To elimi-
nate the confounding effects of the multiple FA species, we
initially established a method that enables us to selectively
increase circulating palmitate levels. Because FA ethyl esters
are known to be rapidly hydrolyzed in the blood of rodents (Hun-
gund et al., 1995), we tested whether emulsified ethyl palmitate,
which can be intravenously administered, could be used for that
purpose. When emulsified ethyl palmitate was incubated in
mouse serum, it was rapidly hydrolyzed to free (nonesterified)
FA, as expected (Figure S1A). When the emulsified ethyl ester
solution (600 mM) was continuously infused (0.2 ml/min) into
mice via the jugular vein for 2 hr or 14 hr, the serum FFA levels
were significantly increased (Figure S1B) and, more importantly,
only the palmitate levels were significantly increased among the
major FFA species, as compared with vehicle infusion (Figures
1A and S1C).
We then tested whether ethyl palmitate infusion would affect
b cell function in mice. Intravenous glucose tolerance tests
(IVGTTs) showed that the acute insulin response (AIR) (Mar-
celli-Tourvieille et al., 2006) was increased by a 14 hr infusion
of ethyl palmitate, as compared to the baseline level, while longer
infusions progressively impaired acute insulin secretion (Figures
S1D and S1E). These results are compatible with earlier findings
that, in bothmice and humans, a short term infusion of emulsified
soybean triglycerides plus heparin augmented glucose-induced
insulin secretion (GSIS), in part via the GPR40 FFA receptor
(Steneberg et al., 2005), while longer infusion impaired it (Car-
pentier et al., 2000). Importantly, however, the expression levels
of genes involved in b cell function, including Pdx1, Insulin
(mature Ins1 and Ins2 mRNA), and Ins2 pre-mRNA (which more
accurately reflects transcription rates) (Iype et al., 2005), were
already significantly reduced in islets from mice infused with
ethyl palmitate for 14 hr, as compared to those frommice infused
with vehicle (Figure 1B). These results strongly suggest that
continuous ethyl palmitate infusion induces b cell dysfunction
within 14 hr. Indeed, GSIS in islets isolated from mice infused
with ethyl palmitate was significantly diminished, as compared
to the vehicle-infused controls (Figure 1C). And when increasing
doses of ethyl palmitate (0.72, 2.2, 7.2 mmol/hr) were infused,
there tended to be a dose dependency in the suppression of
gene expression and the levels of PDX-1 protein (Figures S1G
and S1H). It thus appears that palmitate rapidly induces b cell
dysfunction in vivo, despite the apparent early augmentation of
insulin secretion. We therefore focused on the mechanism by
which palmitate induces rapid b cell dysfunction.
The TLR4/MyD88 Pathway Is Essential for Palmitate-
Induced b Cell Dysfunction In Vivo, but Not In Vitro
TLR4 is known to mediate the response to palmitate in macro-
phages in vitro (Suganami and Ogawa, 2010). TLR4 is expressed
in b cells (Goldberg et al., 2007; Vives-Pi et al., 2003), and the
binding of chemokine CXCL10 to TLR4 induces b cell apoptosis
(Schulthess et al., 2009). These earlier findings prompted us to
test whether TLR4 signaling might be involved in palmitate-
induced b cell dysfunction. When we infused ethyl palmitate
into Tlr4 and Myd88 (encoding TLR4’s adaptor protein MyD88)
knockout mice, the infusion did not reduce expression of Pdx1,
Insulin, and Ins2 pre-mRNA or PDX1 protein in the islets ofell Metabolism 15, 518–533, April 4, 2012 ª2012 Elsevier Inc. 519
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Figure 1. Ethyl Palmitate Infusion Induces b Cell Dysfunction via the TLR4/MyD88 Pathway
(A) Mice were continuously infused for 14 hr with ethyl palmitate or vehicle, after which serum levels of each free FA were analyzed. n = 4 mice for each group.
*p < 0.05. Error bars, SEM.
(B) Effects of ethyl palmitate infusion on expression of b cell-associated genes. Islets were collected from mice infused for 14 hr with ethyl palmitate or vehicle.
Levels of mRNA expression were analyzed using real-time PCR. mRNA expression levels were normalized first to those of 18 s rRNA and then further normalized
to the levels in vehicle-treated mice. n = 4 mice in each group.
(C) Effects of ethyl palmitate infusion on GSIS. The islets isolated fromwild-type (WT), Tlr4/, andMyd88/mice infused for 14 hr with ethyl palmitate or vehicle
were stimulated for 1 hr with KRB buffer containing 2.8 mM or 22.4 mM glucose, and the insulin secreted into the buffer was assayed. Insulin levels in the buffer
were normalized to the insulin content. n = 5–9 islet preparations. Shown are representative data from three or more experiments.
(D and E)Wild-type and Tlr4/micewere infused for 14 hr with ethyl palmitate or vehicle, after which expression of b cell-associated genes (D) and PDX-1 protein
(E) was analyzed in islets isolated from the indicated mice. Expression levels were normalized to the levels in vehicle-treated wild-type mice. For the western
analysis, a representative blot image and relative band intensities are shown. Band intensities were normalized first to those of b-tubulin and then further
normalized to the intensities in vehicle-treated mice. In (D), n = 6 mice in each group; in (E), n = 6 and 5 mice for wild-type and Tlr4/, respectively.
(F) MIN6 b cells were transfected with control siRNA or siRNA targeting Tlr4 and treated with 300 mM palmitate for 48 hr. Levels of mRNA expression of b cell-
associated genes were analyzed. Expression levels were normalized first to those of 18 s rRNA and then further normalized to the levels in control cells. n = 4 in
each group.
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Islet Inflammation in b Cell DysfunctionTlr4/ andMyd88/mice (Figures 1D, 1E, and S2A). Moreover,
impairment of GSIS by ethyl palmitate was not observed in islets
isolated from Tlr4/ and Myd88/ mice (Figure 1C). Collec-
tively, these data demonstrate that the TLR4/MyD88 pathway
is essential for palmitate-induced b cell dysfunction.520 Cell Metabolism 15, 518–533, April 4, 2012 ª2012 Elsevier Inc.We next used MIN6 b cells (Miyazaki et al., 1990) to further
investigate the molecular mechanism by which palmitate
reduces b cell-associated gene expression via the TLR4/
MyD88 pathway. As expected, palmitate reduced expression
levels of Pdx1, Ins2 pre-mRNA, and Insulin (Figure 1F).
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suppress the downregulation of those genes by palmitate
(Figures 1F, S2C, and S2D), indicating the TLR4/MyD88 pathway
was dispensable for palmitate-induced downregulation of b cell-
associated genes in MIN6 cells. One possible explanation for the
discrepancy between the in vivo and in vitro findings is the
involvement of non-cell-autonomous mechanisms in the in vivo
setting.
Palmitate Induces Accumulation of Proinflammatory
Monocytes/Macrophages within Islets
To address the possible involvement of non-b cells in ethyl
palmitate-induced b cell dysfunction, we analyzed the islet cells
by flow cytometry and detected the presence of CD11b+ cells
within isolated islets. The cells were morphologically monocytes
ormacrophages, but not granulocytes (Figure 2A). Moreover, the
majority of CD11b+ cells were negative for Ly-6G, a granulocyte
marker, but did not show the surface phenotypes of dendritic
cells, indicating that islet CD11b+ cells were mainly monocytes
or macrophages (Figures S3A and S3B). To detect any contam-
ination by circulating leukocytes, we also tested for the presence
of red blood cells (RBCs) (Galkina et al., 2006). Based on the
numbers of RBCs and leukocytes in blood, the fraction of
contaminating blood leukocytes within islets was estimated to
be < 0.0021% of the total live cells (see Figure S3C and Supple-
mental Experimental Procedures for further discussion). Thus,
nearly all of the CD11b+ cells appear to be located within the
islets. Furthermore, whole-mount pancreas showed the pres-
ence of CD11b+ cells within islets (Figures 2B and S3D), and
F4/80 staining of formalin-fixed pancreatic sections showed
the presence of F4/80+ macrophages (Figure 2C).
In the following flow cytometric analyses of CD11b+ cells, we
analyzed the cells gated to R1 (Figure S3E), because themajority
of CD11b+ cells were located there (Figure S3F).
Ethyl palmitate infusion increased the size of the overall
CD11b+ cell fraction (Figure 2D). Because recent studies have
shown that macrophages can be divided into several subtypes
(Mosser and Edwards, 2008), we further characterized the
surface phenotypes of CD11b+ cells. We found that ethyl palmi-
tate infusion significantly increased the relative cell fraction of
viable CD11b+Ly-6C+ cells (cells in region R2 in Figure 2E),
whereas the CD11b+Ly-6C (R3) cell fraction was not signifi-
cantly affected (Figure 2E). Similarly, when the numbers of
CD11b+ cells were expressed as total cells per islet, only
CD11b+Ly-6C+ cells were increased (Figure S4A).
F4/80 levels varied widely among CD11b+Ly-6C+ cells, from
low to high (Figure S4B), suggesting the population contained
both newly recruited monocytes and those in transition to
becoming macrophages, as well as mature macrophages (Sun-
derko¨tter et al., 2004; Swirski et al., 2007). CD11b+Ly-6C cells
were largely positive for F4/80 (Figure S4B). Hereafter, these cell
types will be designated as CD11b+Ly-6C+ monocytes/macro-
phages and CD11b+Ly-6C macrophages.
To further characterize the CD11b+ cells, we first sorted them
from the islets (Figure S4C). We then found that CD11b+Ly-6C+
cells expressed Il1b (encoding IL-1b) and Tnfa (encoding
TNF-a), both of which induce b cell dysfunction (Bendtzen
et al., 1986), more strongly than CD11b+Ly-6C macrophages
(Figure 2F). By contrast, CD11b+Ly-6C macrophages ex-Cpressed Il10 (Figure 2F). In addition, surface expression of the
M2 markers CD206 and CD301 was significantly higher in
CD11b+Ly-6C cells than CD11b+Ly-6C+ cells (Figure S4D).
Thus CD11b+Ly-6C+ cells exhibit the phenotype of M1 classi-
cally activated inflammatory macrophages, while the character-
istics of CD11b+Ly-6C macrophages suggest an alternatively
activated M2-like phenotype (Mosser and Edwards, 2008).
Ethyl palmitate infusion did not alter the CD11b+Ly-6C+
macrophage populations in the exocrine pancreas (Figure S4E)
or the levels of total and Ly-6C+ inflammatory monocytes in
the circulation (Figure S4F). Taken together, these findings
indicate that palmitate selectively promotes accumulation of
CD11b+Ly-6C+ M1-type monocytes/macrophages within
pancreatic islets.
Islet Cells Are Responsible for Palmitate-Induced
Inflammatory Macrophage Accumulation
We next addressed the mechanism by which palmitate induces
accumulation of inflammatory macrophages within islets. We
found that ethyl palmitate infusion did not induce accumulation
of CD11b+Ly-6C+ cells in the islets of Tlr4/ and Myd88/
mice, indicating that the TLR4/MyD88 pathway is involved
(Figures 3A and S5A).
We then asked which cell types are responsible for initiating
CD11b+Ly-6C+ cell accumulation. Because the TLR4/MyD88
pathway is known to be important for immune cell function (Ka-
wai and Akira, 2009), we tested whether the absence of TLR4/
MyD88 signaling in bone marrow (BM)-derived cells might
underlie the reduced macrophage accumulation in Tlr4/ and
Myd88/ mice. We generated Tlr4 knockout mice whose BM
was replaced with wild-type BM. Flow cytometric analysis using
Ly-5.1 antibody indicated that > 85% of peripheral blood leuko-
cytes were reconstituted in the BM-transplant recipient mice
(data not shown). In the wild-typemice with wild-type BM, palmi-
tate induced accumulation of CD11b+Ly-6C+ cells within the
islets (Figure 3B). In Tlr4/ mice with the wild-type BM,
however, ethyl palmitate infusion failed to increase the CD11b+
Ly-6C+ cell fraction within the islets, indicating that restoration
of the TLR4 pathway in BM-derived cells was not sufficient to
recruit CD11b+Ly-6C+ cells to the islets.
We also generated mice whose BM was replaced with Tlr4/
BM. Interestingly, in response to ethyl palmitate, Tlr4/
CD11b+Ly-6C+ cells accumulated within islets as efficiently as
wild-type cells did (Figure 3C). Clearly, while a TLR4 pathway
in non-BM cells is indispensable for palmitate-induced recruit-
ment of M1-type cells to islets, TLR4 appears to be dispensable
for the initial accumulation of M1-type cells. BM Tlr4 deletion
also did not significantly reduce the expression of Il1b or Tnfa
within islets in response to ethyl palmitate, though Il1b levels
tended to be modestly reduced (Figure S5B). These results
suggest that Tlr4 in hematopoietic cells is dispensable, at least
for the initial activation of inflammatory processes.
b Cells Initiate Macrophage Accumulation by
Responding to Palmitate via the TLR4/MyD88 Pathway
We hypothesized that b cells initiate macrophage recruitment in
response to palmitate. To test that idea, we first assessed the
capacity of b cells to promote macrophage recruitment using
cultured cells. We found that medium conditioned byell Metabolism 15, 518–533, April 4, 2012 ª2012 Elsevier Inc. 521
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Figure 2. Palmitate Induces Accumulation of Proinflammatory Macrophages within Islets
(A) Representative cytospin preparations of CD11b+Ly-6C+ and CD11b+Ly-6C cells isolated from mice infused with ethyl palmitate. Cells were stained with
Giemsa. Scale bar, 10 mm.
(B and C) Immunohistochemical identification of CD11b+ (B) and F4/80+ (C) cells in islets. For CD11b staining, whole-mount pancreatic tissues frommice infused
for 14 hr with vehicle or ethyl palmitate (EP) were immunostained for CD11b and insulin. Representative planes from the Z-stack images are shown. Themaximum
intensity projection views are shown in Figure S3D. Nuclei were counterstained with Hoechst 33342. Scale bars, 50 mm. CD11b, green; insulin, red; nuclei, blue.
For F4/80 staining, formalin-fixed paraffin-embedded sections of pancreas were immunostained for F4/80 (brown). Nuclei were counterstained with hematoxylin.
Scale bar, 50 mm.
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Islet Inflammation in b Cell Dysfunctionpalmitate-treated MIN6 b cells induced migration of RAW264.7
cells more effectively than medium conditioned by vehicle-
treated cells, and knocking down Tlr4 and Myd88 in MIN6 cells
using specific siRNAs abolished the induction of RAW264.7
migration by conditioned medium (Figure 3D).
We next addressed the mechanisms by which b cells promote
macrophage accumulation in islets. We systematically analyzed
secretion of chemokines and cytokines from MIN6 cells (Fig-
ure S5C). We found that palmitate induced expression and
secretion of the chemokines CCL2/MCP-1 and CXCL1/chemo-
kine KC in MIN6 cells, and that knocking down Tlr4 and Myd88
suppressed the palmitate-induced upregulation of Ccl2 and
Cxcl1 and their secretion (Figures 3E, S5C, and S5D). Similarly,
ethyl palmitate infusion induced chemokine expression within
islets in vivo, and ablation of Tlr4 andMyd88 abolished that effect
(Figures 3F and S2B). We then isolated b cells from islets and
further confirmed that palmitate increases the cells’ expression
of Ccl2 and Cxcl1 in vivo (Figure 3G). To further test if b cells
might respond to palmitate via TLR4, we cultured b cells isolated
from islets of wild-type and Tlr4/ mice. When isolated b cells
were cultured in a dish coatedwith laminin, which was previously
shown to support b cell survival and Cxcl1 expression (Ribaux
et al., 2007), the cells isolated from wild-type islets responded
to palmitate by expressing Cxcl1 (Figure S5E). By contrast, cells
from Tlr4/ islets did not respond to palmitate, indicating that
b cells sense palmitate via TLR4. Ccl2 expression was undetect-
able under these culture conditions. Taken together, these
results indicate that b cells sense palmitate and express Ccl2
and Cxcl1 via TLR4/MyD88 signaling.
The NF-kB pathway is known to be activated by TLR4 and to
control expression of chemokine genes (Kawai and Akira, 2009).
As expected, palmitate rapidly (within 20 min) induced phos-
phorylation of IKK in MIN6 cells, and this effect was suppressed
by knockdown of Tlr4 (Figure 3H). Moreover, inhibitors of NF-kB
signaling (BMS-345541 and SC-514) significantly suppressed
the palmitate-induced upregulation of Ccl2 and Cxcl1 expres-
sion in MIN6 cells (Figure 3I). On native polyacrylamide gels,
the band for the TLR4/MD2 complex was shifted in the presence
of palmitate, as it was with lipid IVa, indicating that palmitate
interacts with TLR4/MD2 (Figure S5F). Collectively then, these
results indicate that palmitate induces expression of chemokine
genes in b cells via TLR4/MyD88/NF-kB signaling.
Although ethyl palmitate was rapidly hydrolyzed to palmitate in
the blood (Figures 1A and S1A–S1C), it was still possible that the
unhydrolyzed ester might also stimulate chemokine expression
via the TLR4/MyD88. To test this possibility we treated MIN6
cells with ethyl palmitate and found that, in contrast to palmitate,
ethyl palmitate did not induce chemokine expression in MIN6
cells (Figure S5G). This supports the notion that palmitate, but
not ethyl palmitate, is responsible for the observed effects of
ethyl palmitate infusion on islets in vivo. High glucose levels(D) Flow cytometric analysis of CD11b+ cells within the R1 region (Figure S3E) amo
mice for each group. *p < 0.05. Error bars, SEM.
(E) Flow cytometric analysis of the surface expression of CD11b and Ly-6C. Sh
fractions among the total live cells. n = 3 mice for each group. The same data ex
(F) mRNA expression of M1 andM2marker genes in CD11b+Ly-6C+ and CD11b+L
were normalized first to those of 18 s rRNA and then further normalized to the leve
n = 3 mice for each group. ND, nondetectable.
Cmight also affect chemokine expression as shown by the induc-
tion of IL-1b in isolated islets ex vivo (Maedler et al., 2002).
However, infusion of ethyl palmitate either reduced or did not
significantly affect blood glucose levels in wild-type, Tlr4/, or
Myd88/ mice (Figure S5H). It is therefore very unlikely that
glucose levels contribute to chemokine induction by ethyl palmi-
tate in the present model.
We then tested whether CCL2 might be important for the
accumulation of CD11b+Ly-6C+ cells. We found that ethyl palmi-
tate infusion was not capable of increasing CD11b+Ly-6C+ pop-
ulations in the islets of Ccl2/mice (Figure 3J), which indicates
CCL2 is indispensable for the accumulation of these cells within
islets in response to palmitate. Unexpectedly, however, the ethyl
palmitate-induced CD11b+Ly-6C+ cell accumulation was not
affected by deletion ofCcr2, a gene encoding the CCL2 receptor
(Figure S5I), which suggests a compensatory mechanism for
CD11b+Ly-6C+ cell recruitment is active inCcr2/mice (Gutier-
rez et al., 2011).
The results presented so far strongly suggest that b cells sense
palmitate via TLR4 and are responsible for the recruitment of
inflammatory macrophages, in part via production of CCL2.
However, it has been shown that endothelial cells and macro-
phages can also expressCcl2. We found that whileCcl2was ex-
pressed in CD11bLy-6C+CD31+ endothelial cells and resident
CD11b+Ly-6C macrophages, ethyl palmitate infusion did not
alter its expression levels in these cell types (Figure S5J). There-
fore, b cells appear to be the only population within islets that
exhibits increasedCcl2 expression in response to ethyl palmitate
infusion. Although levels of Ccl2 expression in b cells are lower
than in resident macrophages, the b cell fraction in islets is
much larger than the macrophage fraction. This makes it very
likely that b cells are responsible for initiating the accumulation
of CD11b+Ly-6C+ cells in islets in response to palmitate. Once
CD11b+Ly-6C+ cells are recruited, they might also contribute
to further recruitment.
Previous studies demonstrated that different FA species exert
different effects on cellular function. We therefore compared
effects of palmitate (C16:0), myristate (C14:0), and oleate
(C18:1). Oleate modestly upregulated expression of Ccl2 and
Cxcl1 in MIN6 cells, but myristate had no effect on expression
of these genes (Figure 3K). We then continuously infused emul-
sified ethyl esters of the FAs and found that, whereas ethyl oleate
stimulated the accumulation CD11b+Ly-6C+ cells within islets,
myristate did not affect the cell fraction (Figure 3L). These in vivo
findings (Figure 3L) may reflect the effects on chemokine expres-
sion observed in vitro (Figure 3K).
Palmitate Induces Inflammatory Interactions between
b Cells and Macrophages
Our results suggest that recruited inflammatory macrophages
are involved in b cell dysfunction. Consistent with that notionng cells isolated frommice infused for 14 hr with ethyl palmitate or vehicle. n = 6
own are representative plots and the CD11b+Ly-6C+ and CD11b+Ly-6C cell
pressed as cell numbers per islet are shown in Figure S4A.
y-6C cells within islets of mice administered ethyl palmitate. Expression levels
ls in CD11b+Ly-6C+ cells (for Il1b and Tnfa) or in CD11b+Ly-6C cells (for Il10).
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Figure 3. Palmitate Induces Chemokine Gene Expression in b Cells via the TLR4/MyD88 Pathway
(A) Wild-type and Tlr4/mice were infused for 14 hr with ethyl palmitate (EP) or vehicle, after which cells within islets were analyzed by flow cytometry. n = 4mice
for each group. *p < 0.05. Error bars, SEM.
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Islet Inflammation in b Cell Dysfunctionand in contrast to the improved GSIS observed in MIN6 cells
incubated for 14 hr in the presence of palmitate, coculturing
MIN6 b cells with RAW264.7 cells (Figure 4A) or bone marrow-
derivedmacrophages (Figure S6A) at a ratio of 100:1 significantly
impaired GSIS in MIN6 cells. To test whether this apparent
cellular interaction might be mediated by humoral factors,
MIN6 and RAW264.7 cells were separately cultured in the
bottom and inner wells of Boyden chambers, which permitted
passage of humoral factors between the chamber wells. When
RAW264.7 cells were present, palmitate reduced expression of
Pdx1, Ins2 pre-mRNA, and Insulin, as well as PDX1 protein, in
MIN6 cells to a greater degree than when MIN6 cells were
cultured alone (Figures 4B and 4C). Moreover, medium condi-
tioned by palmitate-treated RAW264.7 cells reduced expression
of b cell-associated genes inMIN6 cells, and amixture of neutral-
izing antibodies against IL-1b and TNF-a partially suppressed
the effects of the conditioned medium (Figure S6B). The condi-
tioned medium also impaired GSIS in MIN6 cells, and the
neutralizing antibodies partially restored GSIS (Figure S6C).
Finally, addition of IL-1b and TNF-a to the culture medium sup-
pressed expression of b cell-associated genes (Figure S6D).
These results demonstrate that cytokines, including IL-1b and
TNF-a, secreted from RAW264.7 cells impair MIN6 b cell func-
tion. The involvement of these cytokines in palmitate-induced
b cell dysfunction in vivo is also supported by the finding that
expression of Il1b and Tnfa within islets was increased by ethyl
palmitate infusion and that this response was abolished in
Tlr4/ and Myd88/ mice (Figure S6E).
Interestingly, coculturing MIN6 with RAW264.7 cells markedly
enhanced palmitate-induced expression of Ccl2 and Cxcl1 in
MIN6 cells, as compared to MIN6 cells cultured alone (Fig-
ure 4B). In RAW264.7 cells, palmitate increased levels of Il1b
and Tnfa expression (Figure 4D). Coculturing of RAW264.7(B)Wild-type and Tlr4/micewhose BMhad been replacedwith wild-type BM (W
after which the CD11b+Ly-6C+ cell fractions among islet cells were analyzed. WT
n = 3, ethyl palmitate n = 4.
(C) Wild-type mice whose BM had been replaced with either wild-type or Tlr4/
vehicle, after which the CD11b+Ly-6C+ cell fractions among the islet cells were an
(D) Effect of MIN6-conditionedmedium on RAW264.7 cell migration. MIN6 cells w
with palmitate (300 mM) or vehicle, as indicated. Medium conditioned by MIN6 c
RAW264.7 cells that migrated through the porous membranes were determined
(E) MIN6 b cells were transfected with control siRNA or siRNA targeting Tlr4 a
expression of chemokine genes were analyzed. Expression levels were normalize
cells. n = 4 in each group. NS, not significant.
(F) Wild-type (WT) and Tlr4/mice were infused with ethyl palmitate or vehicle as
n = 5 and 6 mice for vehicle and ethyl palmitate, respectively.
(G) b cells were isolated from mice infused for 14 hr with ethyl palmitate or vehic
(H) MIN6 b cells were transfected with either control siRNA or siRNA targeting Tlr4
analyzed. Shown are representative blots and relative band intensities normalize
(I) Effects of NF-kb inhibition on chemokine gene expression in MIN6 cells. The ce
(3 mM) or SC-514 (10 mM), or with vehicle. Thereafter, 300 mMpalmitate or vehicle
were normalized first to those of 18 s rRNA and then further normalized to the le
(J) Wild-type (WT) andCcl2/mice were infused with vehicle or ethyl palmitate fo
each group.
(K) MIN6 cells were treated with 300 mM palmitate, myristate (C14:0), oleate (C1
analyzed. Expression levels were normalized first to those of 18 s rRNA and then
versus vehicle. Error bars, SEM.
(L) Flow cytometric analysis of islet CD11b+ cells from mice administered various
oleate, or vehicle, after which CD11b+ cells within islets isolated from these mice
vehicle. Error bars, SEM.
Cand MIN6 cells significantly augmented the palmitate-induced
expression of Il1b and Tnfa in RAW264.7 cells, as compared
to RAW264.7 cells cultured alone (Figure 4D). These results
suggest that an interaction between RAW264.7 and MIN6 cells
augments the inflammatory interactions. The findings that
medium conditioned by palmitate-treated RAW264.7 cells
induced Ccl2 and Cxcl1 in MIN6 cells and that this induction
of chemokine genes was significantly inhibited by neutralizing
antibodies against IL-1b and TNF-a (Figure S6B), indicate that
the inflammatory interactions are at least partly mediated by
cytokines. Thus, once CD11b+Ly-6C+ cells had accumulated,
the interactions between b cells and macrophages likely exac-
erbated b cell dysfunction and the inflammation induced by
palmitate.
Inflammatory Macrophages Are Essential for Palmitate-
Induced b Cell Dysfunction In Vivo
We next assessed the involvement of macrophages recruited to
islets in palmitate-induced b cell dysfunction in vivo by depleting
macrophages using clodronate-filled liposomes, which are in-
gested by monocytes and macrophages, after which intracel-
lular release of clodronate causes apoptosis (Van Rooijen and
Sanders, 1994). We intraperitoneally administered either clodro-
nate or empty liposomes 54 hr and then 6 hr prior to the start of
the ethyl palmitate infusion. As expected, the clodronate lipo-
somes depleted macrophages in the liver and spleen, as well
as circulating monocytes (data not shown), and they also in-
hibited the accumulation of CD11b+Ly-6C+ inflammatory cells
within islets in response to ethyl palmitate infusion (Figure 5A).
They did not have a significant effect on the CD11b+Ly-6C
macrophage fractions, however. Because circulating Ly-6C+
inflammatory monocytes are known to be recruited to sites of
inflammation, where they differentiate into M1 macrophagesT/WTandWT/Tlr4/) were infused for 14 hr with ethyl palmitate or vehicle,
BM/WT: vehicle n = 3 mice, ethyl palmitate n = 5; WT BM/TLR4/: vehicle
BM (WT/WT and Tlr4//WT) were infused for 14 hr with ethyl palmitate or
alyzed. n = 3 and 4mice for the vehicle and ethyl palmitate groups, respectively.
ere transfected with control siRNA or siRNA targeting Tlr4 orMyd88 and treated
ells was added to the bottom wells of Boyden chambers, and the fractions of
. n = 4 wells for each group.
nd treated with 300 mM palmitate for 48 hr as in Figure 1F. Levels of mRNA
d first to those of 18 s rRNA and then further normalized to the levels in control
in Figure 1B, and chemokine gene expression was analyzed in isolated islets.
le, and levels of mRNA expression were analyzed. n = 9 mice for each group.
and then treated with 300 mMpalmitate for 20min. Phosphorylation of IKK was
d to b-tubulin. n = 3.
lls were incubated for 1 hr with either of the Ikb kinase inhibitors BMS-245541
was added, and the incubation was continued for 14 hr. Gene expression levels
vels in cells treated with vehicle and BSA. n = 3 in each group.
r 14 hr, after which the islet cells were analyzed by flow cytometry. n = 3 mice in
8:1), or vehicle (BSA) for 14 hr, after which chemokine gene expression was
further normalized to the levels in control cells. n = 4 in each group. *p < 0.05
fatty acids. Mice were continuously infused for 14 hr with ethyl myristate, ethyl
were analyzed by flow cytometry. n = 3 mice in each group. *p < 0.05 versus
ell Metabolism 15, 518–533, April 4, 2012 ª2012 Elsevier Inc. 525
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Figure 4. RAW264.7 Cells Induce MIN6 b Cell Dysfunction
(A) MIN6 cells were cocultured with RAW264.7 cells at a ratio of 100:1 (MIN6 versus RAW264.7) and then incubated for 14 hr with palmitate or vehicle, after
which GSIS was analyzed. MIN6 cells cultured alone were similarly treated with palmitate and analyzed. n = 3 wells in each group. *p < 0.05. Error bars,
SEM.
(B and C) MIN6 cells were plated in the bottom wells of Boyden chambers, with or without RAW264.7 cells in the inserts, as indicated. The cells were then treated
for 48 hr with palmitate or vehicle, after which mRNA and PDX-1 protein expression levels in the MIN6 cells were analyzed. In (B) expression levels were
normalized first to those of 18 s rRNA and then further normalized to the levels in MIN6 cells cultured alone and treated with vehicle. n = 5 wells in each group. In
(C), levels of PDX-1 protein in MIN6 cells were analyzed by western blotting. Relative band intensities were normalized first to those of b-tubulin and then further
normalized to the levels in MIN6 cells cultured alone and treated with vehicle. n = 3.
(D) RAW264.7 cells were plated in the inserts, with or withoutMIN6 cells in the bottomwells, andwere treatedwith vehicle or palmitate as in (B). mRNA expression
in RAW264.7 cells was then analyzed. Expression levels were normalized first to those of 18 s rRNA and then further normalized to the levels in RAW264.7 cells
cultured alone and treated with vehicle. n = 3 in each group.
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Islet Inflammation in b Cell Dysfunction(Geissmann et al., 2010; Sunderko¨tter et al., 2004), these results
strongly suggest that clodronate liposomes block the accumula-
tion of CD11b+Ly-6C+ cells by depleting circulating monocytes,
but they do not significantly affect resident CD11b+Ly-6C
macrophages in the model we utilized.526 Cell Metabolism 15, 518–533, April 4, 2012 ª2012 Elsevier Inc.Administration of clodronate liposomes abolished the palmi-
tate-induced downregulation of Pdx1, Insulin, and Ins2 pre-
mRNA and inhibited the upregulation of Il1b and Tnfawithin islets
(Figure 5B). These in vivo findings, along with the results of the
coculture experiments, demonstrate that CD11b+Ly-6C+
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Figure 5. Recruited CD11b+Ly-6C+ Monocytes/
Macrophages Induce b Cell Dysfunction
Clodronate or empty liposomes were intraperitoneally in-
jected into mice 54 hr and then 6 hr prior to the start of ethyl
palmitate infusion. The mice were then infused for 14 hr with
ethyl palmitate or vehicle. In (A), islet macrophages were
analyzed by flow cytometry. Vehicle: n = 3 mice; palmitate:
n = 4. In (B), mRNA expression in islets was analyzed.
Expression levels were normalized first to those of 18 s rRNA
and then further normalized to the levels in mice administered
empty liposomes and vehicle. n = 6 mice. *p < 0.05. Error
bars, SEM.
Cell Metabolism
Islet Inflammation in b Cell Dysfunctioninflammatory macrophages play a causative role in palmitate-
induced b cell dysfunction.
Inflammatory Macrophages Play an Important Role
in b Cell Dysfunction in db/db and KKAy Mice
Clinical studies have revealed an association between T2D and
FFAs (Cnop, 2008; Rise´rus et al., 2009). Our results demonstrate
that inflammatory processes involving M1-type monocytes/
macrophages play an essential role in b cell dysfunction induced
by palmitate and suggest that inflammation might be involved in
the development of T2D. To begin testing this hypothesis, we
analyzed the involvement of macrophages in b cell dysfunction
in a well-established T2D model, db/db mice. We found that
serum FFA levels were elevated in db/db mice, as compared to
control db/+ mice (Figure S7A). We initially analyzed expression
of PDX-1 and inflammatory cytokine genes within islets isolated
from db/db and db/+ mice fed a normal chow diet. Levels of
PDX-1 protein were reduced in the db/db pancreas (Figure 6A).
On the other hand, levels ofCcl2,Cxcl1, Il1b, andTnfa expression
were significantly higher indb/db thandb/+ islets (Figure 6B), indi-
cating activation of inflammatory processes in the db/db islets.
Flow cytometric analysis showed that total islet CD11b+ cell
fractions did not significantly differ between db/+ and db/dbCell Metabolismmice (Figure 6C), though the CD11b+Ly-6C+
M1-type cell fraction was significantly larger in
db/db than db/+ islets. By contrast, the CD11b+
Ly-6C macrophage fractions were not signifi-
cantly different between db/db and db/+ islets.
To directly analyze the involvement of macro-
phages in the b cell dysfunction seen in db/db
mice, we administrated clodronate liposomes to
mice weekly, beginning when they were 5 weeks
old. There were no significant differences in body
weights between the two groups throughout the
study (Figure S7B). Administration of clodronate
liposomes suppressed the accumulation of
CD11b+Ly-6C+ M1-type cells within islets (Fig-
ure 6D), while the CD11b+Ly-6C macrophage
fractions tended to be reduced, though the differ-
ence was not significant. Levels of Pdx1, Insulin,
and Ins2 pre-mRNA expression were significantly
lower in islets isolated from db/db mice adminis-
tered empty liposomes than from untreated db/+
mice (Figure 6E). Clodronate liposome administra-
tion increased expression of Insulin, Ins2 pre-mRNA, and Pdx1 mRNA (Figure 6E). Although the upregulation
of Pdx1 mRNA expression was modest following clodronate
liposome administration, levels of PDX-1 protein were approxi-
mately doubled (Figure 6F).
Although insulin tolerance tests (ITTs) indicated no difference
in insulin sensitivity between db/db mice administered empty
or clodronate-filled liposomes (Figure 6G), oral glucose tolerance
tests (OGTTs) showed that clodronate liposomes ameliorated
the glucose intolerance otherwise seen in db/db mice and
improved the insulin secretion elicited by oral glucose (Fig-
ure 6H). Whereas control db/db mice treated with empty lipo-
somes showed no increase in insulin levels 15 min after oral
glucose administration, insulin levels were clearly increased at
that time in db/db mice treated with clodronate liposomes (Fig-
ure 6H) and were significantly correlated with glucose levels
throughout the first 15 min of the OGTT (Figure S7C). This
suggests treatment with clodronate liposomes improved insulin
secretion in response to glucose. Moreover, when the first-
phase insulin response was examined, insulin levels in db/db
mice treated with empty liposomes were paradoxically reduced
2 min after intravenous glucose injection, but levels in db/db
mice treated with clodronate liposomes were increased at the
same time point (Figure S7D). The acute insulin response (AIR)15, 518–533, April 4, 2012 ª2012 Elsevier Inc. 527
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Figure 6. Inflammatory Macrophages Are Crucially Involved in b Cell Dysfunction in db/db Mice
(A) Expression of PDX-1 protein in islets of 10-week-old mice. Relative band intensities were normalized first to those of b-tubulin and then further normalized to
the levels in db/+ mice. n = 3 mice for each group.
(B) Expression of b cell-associated genes and proinflammatory genes was analyzed in islets isolated from 8-week-old db/+ and db/db mice. Expression levels
were normalized first to those of 18 s rRNA and then further normalized to the levels in db/+ mice. n = 4 mice for each group.
(C) Flow cytometric analysis of CD11b+ macrophages within islets. Islets were harvested from 8-week-old db/+ and db/db mice. n = 3 mice for each group.
(D–H) db/db mice were administered clodronate (clo) or empty (emp) liposomes weekly, beginning when they were 5 weeks old. The mice were then analyzed at
10 weeks old, except islet macrophages were analyzed at 8 weeks and ITTs were carried out at 9 weeks. Islet macrophages were analyzed by flow cytometry (D).
Empty liposomes: n = 9 mice; clodronate liposomes: n = 6. Expression of b cell-associated genes within islets was analyzed (E). Expression levels were
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Islet Inflammation in b Cell Dysfunctioncan become negative in T2D subjects (Mari et al., 2008), and
the recovery of the AIR from negative to positive reportedly
associates with improvement of b cell function in T2D subjects
(Li et al., 2004). Therefore, the recovery of the AIR after clodro-
nate liposome administration suggests there was an amelio-
ration of b cell dysfunction. Furthermore, GSIS was restored
in isolated islets from db/db mice administered clodronate
liposomes (Figure 6I). Taken together, these results strongly
suggest that inflammation plays a key role in b cell dysfunction
in db/db mice.
To further confirm that islet inflammation is involved in b cell
dysfunction in T2D, we utilized another widely used T2D model,
KKAymice. As was seen in mice infused with ethyl palmitate and
in db/db mice, the numbers of CD11b+Ly-6C+ cells were
increased in the islets of KKAymice fed a high-fat diet (Figure 7A).
Levels of Insulin and Ins2 pre-mRNA expression were signifi-
cantly lower in islets isolated from KKAy mice administered
empty liposomes than in untreated KKTa mice, whereas Pdx1
levels did not significantly differ (Figure 7B). Clodronate liposome
administration increased expression of Insulin, Ins2 pre-mRNA,
and Pdx1 mRNA (Figure 7B), as compared to administration of
empty liposomes. OGTTs showed that glucose tolerance was
improved in KKAy mice administered clodronate liposomes (Fig-
ure 7C), and both OGTTs and IVGTTs showed that there was
recovery of the early insulin response to glucose (Figures 7C
and S7E). In ITTs, basal glucose levels and levels 20 and
40 min after insulin injection were reduced in KKAy mice admin-
istered clodronate liposomes (Figure 7D). In addition, GSIS
was restored in islets isolated from KKAy mice administered
clodronate liposomes (Figure 7E). These results indicate that
clodronate liposomes ameliorated the b cell dysfunction in
KKAy mice.
DISCUSSION
The results of the present study demonstrate that (1) the satu-
rated FA palmitate induces b cell dysfunction in vivo; (2) b cells
produce chemokines, which recruit CD11b+Ly-6C+ M1-type
cells to islets in response to palmitate via the TLR4/MyD88
pathway; (3) M1-type cells play a pivotal role in palmitate-
induced b cell dysfunction; (4) palmitate induces reciprocal inter-
actions between b cells and macrophages, further augmenting
macrophage recruitment and b cell dysfunction; and (5) M1-
type cell recruitment and inflammation also play a key role in
b cell dysfunction in db/db and KKAy mice. Those results
suggest a model in which b cells respond to endogenous stimuli,
including saturated FFAs, by initiating macrophage recruitment
through production of chemokines, and the subsequent interac-
tions between b cells and M1-type cells propagate and perpet-
uate inflammatory processes within islets that lead to b cell
dysfunction (Figure 7F). Our results thus highlight the causativenormalized first to those of 18 s rRNA and then further normalized to the levels in un
9 mice; clodronate liposomes: n = 6. *p < 0.05 versus db/+. #p < 0.05 versus emp
band intensities were normalized first to those of b-tubulin and then further norma
4mice; clodronate liposomes: n = 5. Results of ITTs (G) and OGTTs (H). In (G), 2.5
for empty and clodronate liposomes, respectively. In (H), 0.5 g/kg glucose wer
respectively. Untreated db/+ mice (n = 8) were similarly analyzed. *p < 0.05 vers
(I) GSIS in islets isolated from db/db mice treated with either empty or clodronat
Cinvolvement of inflammation in b cell dysfunction in T2D. They
also demonstrate that inflammation is integral to lipotoxicity
in vivo.
Our findings demonstrate that b cells play a primary role in
sensing palmitate and initiating inflammatory processes within
islets. Interestingly, however, Ccl2 and Cxcl1 expression was
markedly augmented in MIN6 cells cocultured with RAW264.7
cells (Figure 4B), while Il1b and Tnfa expression was augmented
in RAW264.7 cells cocultured with MIN6 cells (Figure 4D). This
suggests that once M1 macrophages have accumulated within
islets, b cells and macrophages interact reciprocally, at least in
part via cytokines, to further augment and propagate inflamma-
tory processes within the islets. In that regard, our findings
suggest that blocking IL-1b might improve blood glucose levels
and b cell function in T2D patients (Donath and Shoelson, 2011;
Larsen et al., 2007) by interfering with the inflammatory interac-
tion between b cells and macrophages. This notion is consistent
with the finding that neutralizing IL-1b and TNF-a suppressed the
interaction between MIN6 and RAW264.7 cells, but did not
ameliorate the direct deleterious effect of palmitate on MIN6
cells cultured alone (Figure S6B).
Earlier immunohistochemical studies showed that macro-
phages accumulate within the islets of patients with T2D (Ehses
et al., 2007; Richardson et al., 2009) and animal models of T2D,
including diet-induced obese and db/db mice (Ehses et al.,
2007). However, their causative involvement in b cell dysfunc-
tion had not been directly tested (Ehses et al., 2008). Our flow
cytometric analysis unequivocally indicates that CD11b+Ly-
6C+ monocytes/macrophages are recruited to islets in mice
treated with ethyl palmitate, as well as db/db and KKAy mice,
and those recruited cells exhibit the phenotype of M1 activation
(Geissmann et al., 2010; Mosser and Edwards, 2008). Clodro-
nate liposomes inhibited accumulation of CD11b+Ly-6C+
M1-tpe cells and ameliorated b cell dysfunction in ethyl palmi-
tate-infused, db/db, and KKAy mice, clearly indicating that
the recruited M1 cells play a causative role in b cell dysfunction.
Previous studies have shown direct deleterious effects of
FFAs on b cells; this is collectively termed ‘‘lipotoxicity’’ (Fonseca
et al., 2011). In the present study, direct effects of palmitate
on b cells were also observed in cultured MIN6 cells (Fig-
ure 4B). However, our results indicate that, in addition to the
direct toxic effects of lipids, inflammatory processes play
a pivotal role in b cell lipotoxicity in vivo. Given the recent findings
that M1-type macrophages accumulate in adipose tissue
(Hotamisligil, 2006; Maury and Brichard, 2010) and liver (Baffy,
2009) in obese and T2D subjects, the results of the present
study suggest the shift in macrophage polarization is broadly
involved in the metabolic dysfunction associated with obesity
seen in multiple organs. In addition, as FFAs appear to
induce cellular dysfunction in all those tissues, our findings
also suggest that the activation of inflammatory processes bytreated db/+mice. db/+: n = 3mice; db/db administered empty liposomes: n =
ty liposome. Error bars, SEM. Levels of PDX-1 protein are shown (F). Relative
lized to the levels in mice administered empty liposomes. Empty liposomes: n =
IU/kg insulin were intraperitoneally administered to eachmouse; n = 6 or 7 mice
e orally administered; n = 16 or 10 mice for empty or clodronate liposomes,
us db/+. #p < 0.05 versus empty liposome. Error bars, SEM.
e liposomes and db/+ mice. n = 6 islet preparations for each group.
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Figure 7. Involvement of Inflammatory Macrophages in b Cell Dysfunction in KKAy Mice
(A) Flow cytometric analysis of CD11b+ macrophages within islets. Islets were harvested from 8-week-old KKTa mice (n = 5) and KKAy mice fed a HFD from the
age of 5 weeks. n = 3 mice in each group.
(B–D) KKAy mice fed a HFD from the age of 5 weeks were administered clodronate or empty liposomes weekly, beginning when they were 5 weeks old. The mice
were analyzed when they were 7 weeks old, except OGTTs were administered at 6 weeks. Expression of b cell-associated genes within islets was analyzed (B).
Expression levels were normalized first to those of 18 s rRNA and then further normalized to the levels in untreated KKTa. KKTa: n = 3 mice; KKAy administered
with empty liposomes: n = 6; clodronate liposomes: n = 4. *p < 0.05 versus KKTa. #p < 0.05 versus empty liposome. Error bars, SEM. In (C), glucose and insulin
levels during OGTTs entailing oral administration of 1 g/kg glucose are shown; n = 6 and 8 mice for empty and clodronate liposomes, respectively. In (D), 2 IU/kg
insulin were administered; n = 7 and 9 mice for empty and clodronate liposomes, respectively. *p < 0.05 versus empty liposome. Error bars, SEM.
(E) GSIS in islets isolated from db/db mice treated with either empty or clodronate liposomes. n = 6 islet preparations for each group.
(F) A model of palmitate-TLR4 pathway lading to islet inflammation and b cell dysfunction.
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Islet Inflammation in b Cell DysfunctionFFAs may be part of a unified pathogenic mechanism of meta-
bolic disease.
Previous studies showed that ER stress and ROS pathways
are important for b cell lipotoxicity in vitro (Cnop, 2008; Fonseca
et al., 2011). We found that ER stress markers were induced by
palmitate (K.E. and I.M., unpublished data) as previously re-
ported. Our finding that TLR4 was dispensable for the palmi-
tate-induced downregulation of b cell-associated genes in
MIN6 cells makes it likely that ER stress and ROS signaling530 Cell Metabolism 15, 518–533, April 4, 2012 ª2012 Elsevier Inc.can be activated independently of TLR4 signaling. Consistent
with that idea, we found that knocking down Tlr4 did not affect
induction of ER stress markers in MIN6 cells (K.E. and I.M.,
unpublished data). Although our results obtained with the ethyl
palmitate infusion model and db/db and KKAy mice clearly
demonstrate the key involvement of inflammation in lipotoxicity
in vivo, cell autonomous mechanisms mediated by those path-
ways also very likely contribute to b cell lipotoxicity, as reported
previously (Hotamisligil, 2010).
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Islet Inflammation in b Cell DysfunctionIn the present study, we surmised that selective elevation of
palmitate levels among the other circulating FFA species would
be the key to our ability to clearly demonstrate activation of
inflammation via the TLR4 pathway. This is because each FA
species likely affects metabolism and inflammation differently.
For instance, n-3 PUFAs such as eicosapentaenoic acid are
known to exert anti-inflammatory effects (Calder, 2009). It is
therefore tempting to speculate that the effects of proinflamma-
tory FFA species, such as palmitate, are dampened by anti-
inflammatory FFA species, such as n-3 PUFA, in the circulation.
However, the shift in balance between proinflammatory and anti-
inflammatory FAs due to, for example, consumption of a diet rich
in saturated FAs may induce low-level inflammation via the
mechanism demonstrated in the present study, which can even-
tually lead to b cell dysfunction and T2D. Thismodel is supported
by human studies showing an association between dietary and
plasma FA compositions with low-grade inflammation (Giugliano
et al., 2006; Klein-Platat et al., 2005).
In conclusion, the results of the present study clearly demon-
strate that activation of inflammatory processes within islets
leads to b cell dysfunction. The results also strongly suggest
that inflammation is crucially involved in b cell dysfunction in
T2D. The molecular and cellular interactions identified in the
present study could thus provide novel therapeutic targets for
the treatment of T2D.
EXPERIMENTAL PROCEDURES
Ethyl Palmitate Infusion
Ethyl palmitate (Tokyo Chemical Industry) was dissolved with 1.6% lecithin
(Wako) and 3.3% glycerol in water to produce the mixture of 600 mM ethyl
palmitate, 1.2% lecithin, and 2.5% glycerol. This mixture was then emulsified
using a sonicator. The lecithin-glycerol-water solution was used as the vehicle.
Endotoxin levelswere less than the detection limit of the assay kit (0.015 EU/ml)
(Limulus ES-II, Wako). The right jugular veins of two-month-old C57BL/6 mice
(average bodyweight: 23 g) were catheterized using Alzet indwelling catheters.
Following a 100 ml bolus injection of either emulsified ethyl palmitate solution or
vehicle, the mice were continuously infused with the solutions at 0.2 ml/min.
Serum FFA Measurement
Serum lipids were extracted and separated by thin-layer chromatography
(TLC) using hexane/diethyl ether/acetic acid (80:20:1, v/v). FFA spots were re-
vealed using iodine vapor, scraped, and methylated using 1% H2SO4 in meth-
anol. Methylated FAs were then quantified by GS-MS analysis.
Clodronate Liposomes
To deplete circulating monocytes, mice were intraperitoneally injected with
0.01 ml/g body wt clodronate liposomes. For the ethyl palmitate infusion
experiments, clodronate liposomes were administered 54 and then 6 hr prior
to the ethyl palmitate infusion. With db/db and KKAy mice, clodronate lipo-
somes were administered weekly, beginning when the mice were 5 weeks old.
Immunohistochemical Staining
For CD11b staining of whole-mount pancreas, small pieces of pancreatic
tissues were rinsed, fixed in acetone, blocked with 2% bovine serum albumin
in PBS-T, and immunostained. The stained samples were observed using
a confocal laser-scanning microscope (LSM510 Meta, Zeiss). For F4/80 stain-
ing, formalin-fixed paraffin-embedded mouse pancreatic sections were
labeled with an anti-F4/80 primary antibody (serotec; clone CI:A3-1, 1:400),
which was visualized through HRP-DAB detection.
Cell Culture
The murine MIN6 b cell line was kindly provided by Jun-ichi Miyazaki (Univer-
sity of Osaka).CCell Migration Assay
Migration assays were performed using Boyden chambers. RAW264.7 cells
were plated on HTS FluoroBlok inserts with 3 mm pores (Falcon) in serum-
free DMEM. Media conditioned with MIN6 cells transfected with siRNA were
diluted 10 times and added to the lower wells of Boyden chambers.
Statistical Analysis
Data are shown as means ± SEM. Differences in body weight changes were
analyzed using two-way ANOVA. Differences between two groups were
analyzed using Student’s t test. Comparisons among multiple groups
were made using one-way ANOVA followed by a post hoc Tukey-Kramer
test for multiple groups. Values of p < 0.05 were considered significant.
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